Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isomune F
- Development stage
- Unknown
- Lead developer
- Percos
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
Isomune F (marketed as Isomune-F Ear Cleanser) is a veterinary ear hygiene solution developed by Percos and marketed under the Aranex Animal Health brand. Formulated as a non-alcoholic, paraben-free, and dermatologically tested liquid, it is designed for routine ear care in dogs and cats. The solution contains salicylic acid as its key active ingredient, which provides keratolytic, antimicrobial, and anti-inflammatory properties. It effectively removes excess wax, debris, dirt, and discharge from the ear canal, helping to prevent odor, irritation, and bacterial or fungal buildup that can lead to otitis externa.
- Brand names
- Isomune FIsomune-F Ear Cleanser
- Other names
- Aranex Isomune-F Ear Cleanser
02
Targets
IleRS (Isoleucyl-tRNA synthetase)GR (Glucocorticoid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Isomune F.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Isomune F.